Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D05TOJ
|
||||
Former ID |
DIB010843
|
||||
Drug Name |
Peretinoin
|
||||
Synonyms |
Polyprenoic acid; E-5166; NIK-333; Peretinoin (oral); Peretinoin (oral), Kowa; Peretinoin (oral formulation, hepatocellular carcinoma), Kowa Pharmaceutical
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Hepatocellular carcinoma [ICD9: 155; ICD10:C22.0] | Phase 3 | [523972] | ||
Company |
Kowa Pharmaceutical Co Ltd; Eisai Co Ltd
|
||||
Structure |
Download2D MOL |
||||
Formula |
C20H30O2
|
||||
Canonical SMILES |
C(=C(\C=C\C=C(\CC/C=C(/CCC=C(C)C)\C)/C)/C)/C(=O)O
|
||||
CAS Number |
CAS 81485-25-8
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Retinoic acid receptor | Target Info | Modulator | [532310] | |
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.